Anti-CD19 chimeric antigen receptor T cell therapy achieved rapid and sustained remission in a patient with systemic lupus erythematosus-associated refractory immune thrombocytopenia.

IF 3.4 4区医学 Q2 RHEUMATOLOGY

Clinical and experimental rheumatology Pub Date : 2025-05-31 DOI:10.55563/clinexprheumatol/pn0yyk

Xuan Zhao, Lei Zhang, Xiaoyu Zhang, Xiaojun Liu, Yinli Zhang, Yanfen Liu, Ximei Tian, Xueyan Men, Lulu Lv, Yi Feng, Junhong Song, Tan Xie, Shengyun Liu, Yi Zhang

引用次数: 0

查看原文本刊更多论文

抗cd19嵌合抗原受体T细胞治疗在系统性红斑狼疮相关难治性免疫性血小板减少症患者中实现了快速和持续的缓解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and experimental rheumatology 医学-风湿病学

CiteScore

6.10

自引率

18.90%

发文量

377

审稿时长

3-6 weeks

期刊介绍： Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.